Suivre
simon gebremeskel
simon gebremeskel
Univ of Toronto, Dalhousie University, Queens University, Allakos Inc,
Adresse e-mail validée de dal.ca
Titre
Citée par
Citée par
Année
Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
S Gebremeskel, B Johnston
Oncotarget 6 (39), 41600, 2015
1352015
The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer
S Gebremeskel, T LeVatte, RS Liwski, B Johnston, M Bezuhly
International journal of cancer 136 (1), 234-240, 2015
1322015
Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune …
R Aslam, Y Hu, S Gebremeskel, GB Segel, ER Speck, L Guo, M Kim, H Ni, ...
Blood, The Journal of the American Society of Hematology 120 (10), 2127-2132, 2012
1112012
Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody
S Gebremeskel, J Schanin, KM Coyle, M Butuci, T Luu, EC Brock, A Xu, ...
Frontiers in immunology 12, 650331, 2021
1072021
Alternatively activated M2 macrophages improve autologous fat graft survival in a mouse model through induction of angiogenesis
KD Phipps, S Gebremeskel, J Gillis, P Hong, B Johnston, M Bezuhly
Plastic and reconstructive surgery 135 (1), 140-149, 2015
812015
Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer
AJ Gareau, C Brien, S Gebremeskel, RS Liwski, B Johnston, M Bezuhly
Clinical & experimental metastasis 35, 25-35, 2018
702018
Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice
S Gebremeskel, DR Clattenburg, D Slauenwhite, L Lobert, B Johnston
Oncoimmunology 4 (3), e995562, 2015
682015
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
J Schanin, S Gebremeskel, W Korver, R Falahati, M Butuci, TJ Haw, ...
Mucosal immunology 14 (2), 366-376, 2021
612021
Reovirus FAST protein enhances vesicular stomatitis virus oncolytic virotherapy in primary and metastatic tumor models
F Le Boeuf, S Gebremeskel, N McMullen, H He, AL Greenshields, ...
Molecular Therapy-Oncolytics 6, 80-89, 2017
542017
Natural killer T-cell immunotherapy in combination with chemotherapy-induced immunogenic cell death targets metastatic breast cancer
S Gebremeskel, L Lobert, K Tanner, B Walker, T Oliphant, LE Clarke, ...
Cancer immunology research 5 (12), 1086-1097, 2017
472017
Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and …
S Gebremeskel, A Nelson, B Walker, T Oliphant, L Lobert, D Mahoney, ...
Journal for immunotherapy of cancer 9 (3), 2021
402021
CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
L Veinotte, S Gebremeskel, B Johnston
Oncoimmunology 5 (6), e1160979, 2016
372016
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy
AM Szczesniak, RF Porter, JT Toguri, J Borowska-Fielding, ...
Neuropharmacology 113, 627-638, 2017
352017
Effect of N-acetylcysteine on adipose-derived stem cell and autologous fat graft survival in a mouse model
J Gillis, S Gebremeskel, KD Phipps, LA MacNeil, CJ Sinal, B Johnston, ...
Plastic and reconstructive surgery 136 (2), 179e-188e, 2015
342015
Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2
W Qiu, R Lam, O Voytyuk, V Romanov, R Gordon, S Gebremeskel, ...
Acta Crystallographica Section D: Biological Crystallography 70 (10), 2740-2753, 2014
302014
Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas
B Dawod, J Liu, S Gebremeskel, C Yan, A Sappong, B Johnston, ...
Scientific reports 10 (1), 13343, 2020
272020
Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen‐induced arthritis by the chemokine receptor CXCR6
D Slauenwhite, S Gebremeskel, CD Doucette, DW Hoskin, B Johnston
Arthritis & rheumatology 66 (11), 3001-3012, 2014
262014
Selective cannabinoid 2 receptor agonists as potential therapeutic drugs for the treatment of endotoxin-induced uveitis
RF Porter, AM Szczesniak, JT Toguri, S Gebremeskel, B Johnston, ...
Molecules 24 (18), 3338, 2019
252019
Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking
DP Corkery, LE Clarke, S Gebremeskel, J Salsman, J Pinder, C Le Page, ...
Oncogene 37 (2), 174-184, 2018
242018
Promotion of primary murine breast cancer growth and metastasis by adipose-derived stem cells is reduced in the presence of autologous fat graft
S Gebremeskel, J Gencarelli, AJ Gareau, T Levatte, A Dugandzic, ...
Plastic and reconstructive surgery 143 (1), 137-147, 2019
222019
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20